Asterias Biotherapeutics
Why Robinhood?
You can watch AST and buy or sell other stocks, ETFs, and their options commission-free!About AST
Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer.
AST Key Statistics
Stock Snapshot
As of today, Asterias Biotherapeutics(AST) shares are valued at $0.95. The company's market cap stands at 92.97M, with a P/E ratio of -3.54.
On 2026-08-16, Asterias Biotherapeutics(AST) stock opened at —, reached a high of —, and a low of —.
The Asterias Biotherapeutics(AST)'s current trading volume is 0, compared to an average daily volume of 81.23K.
In the last year, Asterias Biotherapeutics(AST) shares hit a 52-week high of $3.75 and a 52-week low of $1.20.
In the last year, Asterias Biotherapeutics(AST) shares hit a 52-week high of $3.75 and a 52-week low of $1.20.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.